"OhioHealth Marion General Hospital is a 250-bed hospital that has provided quality healthcare to the north central Ohio communities since 1920. The hospital offers a comprehensive mix of inpatient and outpatient healthcare services."

During the past decade, OhioHealth Marion General Hospital conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 33 clinical trials were completed, i.e. on average, 29.7% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 31 clinical trials were completed. i.e. 67.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "OhioHealth Marion General Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 56 trials, followed by "SWOG Cancer Research Network" with 29 trials sponsored, "Alliance for Clinical Trials in Oncology" with 18 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "NRG Oncology" with 9 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "OhioHealth Marion General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 71 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "OhioHealth Marion General Hospital" are "Stage IV Lung Cancer AJCC v8" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IVA Lung Cancer AJCC v8" (7 trials), "Stage IVB Lung Cancer AJCC v8" (7 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (6 trials). Many other conditions were trialed in "OhioHealth Marion General Hospital" in a lesser frequency.

Most popular intervention types in "OhioHealth Marion General Hospital" are "Drug" (94 trials), "Other" (79 trials), "Biological" (55 trials), "Procedure" (38 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (37 trials), "Laboratory Biomarker Analysis" (32 trials), "Computed Tomography" (25 trials), "Biospecimen Collection" (24 trials) and "Questionnaire Administration" (24 trials). Other intervention names were less common.

The vast majority of trials in "OhioHealth Marion General Hospital" are 104 trials for "All" genders, 27 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "OhioHealth Marion General Hospital". undefined are not yet recruiting, 41 are recruiting, 66 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in OhioHealth Marion General Hospital, 2 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in OhioHealth Marion General Hospital, 5 "Phase 1" clinical trials were conducted, 66 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".